it could go from 5 to 7 but that leads us to a really good question, the FDA needed intended use to define the precision qualification as it pertained to the images sent.
If the images were not as good, or didn't show that it could do what it said it was intended to do then we could be back 4 or being kicked to the performance data route after 7, where the images and the actual testing data done during investigation period which could be a great place to request more info and thus more time and probably anther sell off :(.
I am not saying we are done for, or anything like that at all. All I am saying is that we are a lot farther out then Dean said/thought we were. if we get a request for labeling, game over we win. But we have not, we get nothing but silence and a very very large sell off. To me that tells me something is not quite right here, and I need to watch it.
Of course it could just be the MM< or the pumpers on message boards you see all over the place. But if there is silence from the company, someone/something will speak for it, that is the market, and market is saying "I'm not so sure about IMGG being approved prior to restricted shares come on line".
Not saying I support GAT or anything, but he has a point on those shares. No one who can sell now who got this at .02 is going to hold on a weak or stagnant stock that raises these type of concerns. Well not when you are holding a 2000-3000% profit, that is just crazy. They will sell to get profits and play with house money, at least that is what I would do.
To me the red flag have been raised and those holders are waiting to sell when they get the chance.
